[1]
|
Global Initiative for Chronic Obstructive Lung Disease (2019) 2020 Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2020 Report. Global Initiative for Chronic Obstructive Lung Disease. https://goldcopd.org/gold-reports/
|
[2]
|
Zatloukal, J., Brat, K., Neumannova, K., Volakova, E., Hejduk, K., Kocova, E., et al. (2020) Chronic Obstructive Pulmonary Disease-Diagnosis and Management of Stable Disease: A Personalized Approach to Care, Using the Treatable Traits Concept Based on Clinical Phenotypes. Position Paper of the Czech Pneu-mological and Phthisiological Society, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 164, 325-356.
|
[3]
|
Gao, P., Zhang, J., He, X., Hao, Y., Wang, K. and Gibson, P.G. (2013) Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PLoS ONE, 8, Article ID: e57678.
https://doi.org/10.1371/journal.pone.0057678
|
[4]
|
Hegewald, M.J., Horne, B.D., Trudo, F., Kreindler, J.L., Chung, Y., Rea, S., et al. (2020) Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2629-2641. https://doi.org/10.2147/COPD.S251115
|
[5]
|
Southworth, T., Higham, A., Kolsum, U., Li, J., Scott, T., Dungwa, J., et al. (2021) The Relationship between Airway Immunoglobulin Activity and Eosinophils in COPD. Journal of Cellular and Molecular Medicine, 25, 2203-2212.
https://doi.org/10.1111/jcmm.16206
|
[6]
|
于春歌, 华毛. AECOPD患者炎症表型及炎性标志物研究进展[J]. 临床肺科杂志, 2018, 23(10): 1887-1890.
|
[7]
|
Guo, X.X., Deng, N.S., Chen, Q.H., Yu, H.Y., Ding, X.H., Hu, S.P., et al. (2019) Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests. Current Medical Science, 39, 560-567. https://doi.org/10.1007/s11596-019-2074-7
|
[8]
|
Global Initiative for Chronic Obstructive Lung Disease (2018) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2018 Report. Global Initiative for Chronic Obstructive Lung Disease. https://goldcopd.org/
|
[9]
|
Garudadri, S. and Woodruff, P.G. (2018) Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers. Annals of the American Thoracic Society, 15, S234-S238.
https://doi.org/10.1513/AnnalsATS.201808-533MG
|
[10]
|
Bakeer, M., Funk, G.C. and Valipour, A. (2020) Chronic Obstructive Pulmonary Disease Phenotypes: Imprint on Pharmacological and Non-Pharmacological Therapy. Annals of Translational Medicine, 8, 1472.
https://doi.org/10.21037/atm-20-2219
|
[11]
|
Crespo-Lessmann, A., Plaza, V. and Consensus Group (2020) Multi-disciplinary Consensus on Sputum Induction Biosafety during the COVID-19 Pandemic. Allergy, 76, 2407-2419. https://doi.org/10.1111/all.14697
|
[12]
|
De Nijs, S.B., Fens, N., Lutter, R., Dijkers, E., Krouwels, F.H., Smids-Dierdorp, B.S., et al. (2011) Airway Inflammation and Mannitol Challenge Test in COPD. Respiratory Research, 12, Article No. 11.
https://doi.org/10.1186/1465-9921-12-11
|
[13]
|
刘超, 王伟. 慢性阻塞性肺疾病患者诱导痰中正五聚蛋白3水平的变化及意义[J]. 中国老年学杂志, 2014(24): 6951-6952.
|
[14]
|
Zhu, T., Li, S., Wang, J., Liu, C., Gao, L., Zeng, Y., et al. (2020) Induced Sputum Metabolomic Profiles and Oxidative Stress Are Associated with Chronic Obstructive Pul-monary Disease (COPD) Severity: Potential Use for Predictive, Preventive, and Personalized Medicine. EPMA Journal, 11, 645-659. https://doi.org/10.1007/s13167-020-00227-w
|
[15]
|
Lai, T., Xiang, F., Zeng, J., Huang, Y., Jia, L., Chen, H., et al. (2020) Reliability of Induced Sputum Test Is Greater Than That of Throat Swab Test for Detecting SARS-CoV-2 in Patients with COVID-19: A Multi-Center Cross-Sectional Study. Virulence, 11, 1394-1401. https://doi.org/10.1080/21505594.2020.1831342
|
[16]
|
Davoine, F. and Lacy, P. (2014) Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity. Frontiers in Immunology, 5, Article No. 570. https://doi.org/10.3389/fimmu.2014.00570
|
[17]
|
Bradford, E., Jacobson, S., Varasteh, J., Comellas, A.P., Wood-ruff, P., O’Neal, W., et al. (2017) The Value of Blood Cytokines and Chemokines in Assessing COPD. Respiratory Re-search, 18, Article No. 180.
https://doi.org/10.1186/s12931-017-0662-2
|
[18]
|
杜伟. IL-8的变化在慢阻肺患者血清及支气管肺泡灌洗液中的应用价值研究[J]. 中外医学研究, 2018, 16(23): 14-16.
|
[19]
|
Aslani, M.R., Ghazaei, Z. and Ghobadi, H. (2020) Correlation of Serum Fatty Acid Binding Protein-4 and Interleukin-6 with Airflow Limitation and Quality of Life in Sta-ble and Acute Exacerbation of COPD. Turkish Journal of Medical Sciences, 50, 337-345. https://doi.org/10.3906/sag-1909-9
|
[20]
|
Gorska, K., Nejman-Gryz, P., Paplinska-Goryca, M., Korczynski, P., Prochorec-Sobieszek, M. and Krenke, R. (2018) Comparative Study of IL-33 and IL-6 Levels in Different Respiratory Samples in Mild-to-Moderate Asthma and COPD. COPD, 15, 36-45. https://doi.org/10.1080/15412555.2017.1416074
|
[21]
|
王胜, 徐风珍, 陈余清. 慢性阻塞性肺疾病痰液白细胞介素8、6和肿瘤坏死因子测定及其意义[J]. 中华结核和呼吸杂志, 2000, 23(8): 465-467.
|
[22]
|
Grubek-Jaworska, H., Paplińska, M., Hermanowicz-Salamon, J., Białek-Gosk, K., Dąbrowska, M., Grabczak, E., et al. (2012) IL-6 and IL-13 in Induced Sputum of COPD and Asthma Patients: Correlation with Respiratory Tests. Respiration, 84, 101-107. https://doi.org/10.1159/000334900
|
[23]
|
Córdoba-Lanús, E., Baz-Dávila, R., Espinoza-Jiménez, A., Rodríguez-Pérez, M.C., Varo, N., de-Torres, J.P., et al. (2015) IL-8 Gene Variants Are Associated with Lung Function Decline and Multidimensional BODE Index in COPD Patients but Not with Disease Susceptibility: A Validation Study. COPD, 12, 55-61.
https://doi.org/10.3109/15412555.2014.908831
|
[24]
|
Zhang, J., Feng, M.X. and Qu, J.M. (2012) Low Dose The-ophylline Showed An Inhibitory Effect on the Production of IL-6 and IL-8 in Primary Lung Fibroblast From Patients with COPD. Mediators of Inflammation, 2012, Article ID: 492901. https://doi.org/10.1155/2012/492901
|
[25]
|
Qi, Y.J., Sun, X.J., Wang, Z., Bin, Y.-F., Li, Y.-H., Zhong, X.-N., et al. (2020) Richness of Sputum Microbiome in Acute Exacerbations of Eosinophilic Chronic Obstructive Pulmonary Disease. Chinese Medical Journal, 133, 542-551.
https://doi.org/10.1097/CM9.0000000000000677
|
[26]
|
Kume, H., Hojo, M. and Hashimoto, N. (2019) Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorti-costeroids. Frontiers in Pharmacology, 10, Article No. 765.
https://doi.org/10.3389/fphar.2019.00765
|
[27]
|
Lv, M.Y., Qiang, L.X., Li, Z.H. and Jin, S.-D. (2021) The Lower the Eosinophils, the Stronger the Inflammatory Response? The Relationship of Different Levels of Eosinophils with the Degree of Inflammation in Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD). Journal of Thoracic Disease, 13, 232-243.
https://doi.org/10.21037/jtd-20-2178
|
[28]
|
Hastie, A.T., Martinez, F.J., Curtis, J.L., et al. (2017) Association of Sputum and Blood Eosinophil Concentrations with Clinical Measures of COPD Severity: An Analysis of the SPIROMICS Cohort. Lancet Respir Med, 5, 956-967.
https://doi.org/10.1016/S2213-2600(17)30432-0
|
[29]
|
Hartley, B.F., Barnes, N.C., Lettis, S., Compton, C.H., Papi, A., Jones, P., et al. (2020) Risk Factors for Exacerbations and Pneumonia in Patients with Chronic Obstructive Pulmo-nary Disease: A Pooled Analysis. Respiratory Research, 21, Article No. 5. https://doi.org/10.1186/s12931-019-1262-0
|